science wire



Results 1 - 50 of 22718.
1 2 3 4 5 ... 455 Next »

Health - 22.09.2020
Health messages to help stop patient harm in hospitals
A new global research group led by The Australian National University (ANU) will help tackle communication breakdowns in hospitals that contribute to over 450,000 people per year suffering from an avoidable critical incident.

Life Sciences - Health - 21.09.2020
New national imaging center has potential to transform medicine
This three-dimensional view made by UW-Madison's Joseph Kim and Tanner Tenpas with cryo-electron tomography shows microtubules (in cyan) and mitochondria (yellow) - essential cellular components - of an individual neuron from the cortex of a mouse brain.

Health - 21.09.2020
As nation mourns Ruth Bader Ginsburg, a look at advances in pancreatic cancer treatment
Ruth Bader Ginsburg, who served on the Supreme Court since 1993, died of pancreatic cancer Sept. 18. Ginsburg battled cancer several times throughout her life.

Health - 21.09.2020
’Best’ hospitals should be required to deliver tobacco treatment
According to the paper, almost 500,000 Americans die annually from tobacco use, and 16 million have serious tobacco-induced chronic diseases, which results in $170 billion in health care costs.

Health - Innovation - 21.09.2020

Health - Pharmacology - 21.09.2020
Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale
Kisqali is the only CDK4/6 inhibitor, in combination with endocrine therapy, to achieve a perfect 5 out of 5 score - confirming substantial benefit for premenopausal women with HR+/HER2- advanced bre

Health - Pharmacology - 18.09.2020
Patches to detect when a viral disease is about to get worse
Xsensio, an EPFL spin-off, has just been awarded CHF 1.8 million in EU funding to adapt its Lab-on-Skin(TM) sensing patches so that they can detect when a viral illness like the flu or COVID-19 is about to get worse.

Health - 18.09.2020

Health - Social Sciences - 17.09.2020
Call to improve care for dying people in Scottish hospitals
Marie Curie and the University of Glasgow are calling for action to improve the care and experience of dying people in hospitals.

Health - Life Sciences - 17.09.2020
UC San Diego Scientists to Explore New Frontiers in Parkinson’s Disease Research with $7.2M Grant
Aligning Science Across Parkinson's initiative supports international project aiming to unravel the biology of a gene linked to Parkinson's disease In August, a team of researchers at the University

Health - Pharmacology - 17.09.2020
Talk of a "Twindemic"
No one knows what will happen next with COVID-19 still raging, but there is something you can do: Get your flu vaccination Even as the first wave of the pandemic still roils, fears are rising of a second crush of COVID-19 infections.

Health - Campus - 17.09.2020
Clinicians, researchers, patients and the general public are invited to submit questions that could be answered by COVID-19 patient medical record data from 200+ hospitals As the COVID-19 pandemic co

Health - 17.09.2020
Improving immunity through exercise - new advice for healthcare professionals
New advice to help healthcare professionals promote exercise as a way of improving immunity has been launched by a team of medical experts and exercise scientists.

Health - Campus - 16.09.2020
UCL to offer Covid-19 testing for staff and students
UCL has today announced plans to introduce up to 1,000 Covid-19 tests a day for staff and students who experience coronavirus symptoms.

Life Sciences - Health - 16.09.2020
$14 million boost for Parkinson’s disease research
Two new grants totaling nearly $14 million over three years will jump-start research at UC Berkeley into the molecular and genetic causes of Parkinson's disease, a neurodegenerative disorder that afflicts more than 1 million Americans, yet whose cause remains a mystery.

Health - Life Sciences - 16.09.2020
Parkinson’s disease research at UCL gets 19m boost
Parkinson's disease researchers at UCL are launching three new studies to understand causes and progression of the disease, with the aim of finding new approaches to treatment.

Health - Pharmacology - 16.09.2020
New 4m study to advance our understanding of severe coronavirus infection
The University of Liverpool is leading a major new international project to improve our understanding of severe coronavirus infection in humans, together with collaborators from the University of Oxford, Public Health England, the University of Bristol; A*STAR in Singapore; and King Fahd Medical City in Saudi Arabia.

Health - Campus - 16.09.2020
More than half of Year 12 students report poor mental wellbeing since lockdown
A school-based survey of students in Berkshire, Buckinghamshire, Gloucestershire, Oxfordshire and Wiltshire examined over 200 key factors in the lives and expectations of young people, aged 8-18 years, helping to shed light on mental health during lockdown.

Life Sciences - Health - 16.09.2020
Teams get multi-million-dollar awards to study biology of Parkinson’s
Two Yale research teams will each receive approximately $9 million in grants from the Aligning Sciences Across Parkinson's (ASAP) initiative to study the underlying biology of Parkinson's disease.

Health - 16.09.2020
Syrian refugee health workers can help Europe cope with COVID-19
Syrian refugee health workers can help Europe cope with COVID-19
Employing displaced Syrian healthcare workers is a "win-win" for both host communities and refugees as it would strengthen national health services and allow highly-skilled medics to "get on with their lives, rather than just get by", according to a network of UK academics.

Health - Pharmacology - 16.09.2020
RECOVERY COVID-19 phase 3 trial to evaluate Regeneron’s REGN-COV2 antibody cocktail
One of the world's largest efforts to find effective COVID-19 treatments will evaluate the impact of REGN-COV2 on mortality, hospital stays, and the need for ventilation. Regeneron Pharmaceuticals, Inc. and the University of Oxford today announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world's largest randomised clinical trials of potential COVID-19 treatments, will evaluate Regeneron's investigational anti-viral antibody cocktail, REGN-COV2.

Health - Innovation - 16.09.2020
Share Your Location? CMU’s Li Weighs In
Heinz professor offers insight into COVID-19, contact tracing and consumer behavior Since the advent of the internet, and later the ubiquity of smartphones, businesses and the consumer economy have steadily become more digitized.

Life Sciences - Health - 16.09.2020
U-M virtual symposium examines diverse approaches to biological, biomedical research
EVENT ANNOUNCEMENT DATE: 2 p.m. Tuesday, Sept. 29; 9 a.m. Wednesday, Sept.

Health - Pharmacology - 16.09.2020
New Findings Recommend Patients with a Low HIV Viral Load Switch to Second-line Antiretroviral Therapy
New Findings Recommend Patients with a Low HIV Viral Load Switch to Second-line Antiretroviral Therapy
HIV continues to be a major global health issue, having claimed almost 33 million lives.

Health - Pharmacology - 16.09.2020
Australia unprepared for over-the-counter medical cannabis sales
Australia unprepared for over-the-counter medical cannabis sales
Professor Iain McGregor from the Lambert Initiative says it is time for Australia to have a mature approach to consumer access to safe and effective cannabinoid products without a prescription.

Pharmacology - Health - 16.09.2020
Novartis Tafinlar + Mekinist demonstrates long-term, relapse-free survival benefit for high-risk, stage III melanoma patients in study published in NEJM
COMBI-AD is first trial to demonstrate 5-year relapse-free survival with targeted therapy as adjuvant treatment in high-risk patients with stage III BRAF-mutated melanoma 1 Adjuvant treatment with

Health - Campus - 16.09.2020
Opinion: Importance of international solidarity during Covid-19
UCL Medical School (UCLMS) has a number of highly valued international collaborations, enabling cross-country learning and expertise, in support of medical education.

Life Sciences - Health - 15.09.2020
Catalyst Fund selects six projects in its 2020 funding round
The Catalyst Fund - supported by the Bertarelli Foundation - has selected six research projects to fund this year. Led by professors from EPFL and other Swiss Universities, these projects all aim to develop new treatment options for neurological disorders. Created by the Bertarelli Foundation in 2017, the Catalyst Fund aims to invest in translational projects targeting innovative approaches for diseases affecting the brain, spinal cord, peripheral nervous system and sensory organs.

Health - Life Sciences - 15.09.2020
Earliest steps in the development of an immune response
Immunity requires the close cooperation between different types of white blood cells, particularly those called T cells and B cells, which adapt to respond differently to each new infection. The process of white blood cells responding to infections begins earlier than previously thought, according to a new study by scientists at the University of Birmingham.

Computer Science - Health - 15.09.2020

Health - Materials Science - 15.09.2020

Social Sciences - Health - 15.09.2020
Older adults prefer to remain in their home
Older adults prefer to remain in their home
Living at home in old age: This is what most older adults want. As a result, there is a high demand for senior apartments and tailor-made services for the care of older adults in need of assistance in their own households.
1 2 3 4 5 ... 455 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |